Tuesday - November 26, 2024
McDermott Will & Emery Advises AgenT-Biotech on Its Partnership With Inovie Group to Revolutionize Alzheimer's Disease Detection
September 26, 2024
CHICAGO, Illinois, Sept. 26 -- McDermott Will and Emery, a law firm, issued the following news release:

McDermott Will & Emery has advised AgenT-biotech, a pioneering developer of a blood-based diagnostic test for the silent phase of Alzheimer's disease, on its collaboration with INOVIE Group, the world leader in clinical laboratory networks, to revolutionize the detection of Alzheimer's disease.

The McDermott team on this operation was composed of Anne-France Morea . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products